High NPHP1 and NPHP6 mutation rate in patients with Joubert syndrome and nephronophthisis: Potential epistatic effect of NPHP6 and AHI1 mutations in patients with NPHP1 mutations

K. Tory, Tiphanie Lacoste, Lydie Burglen, Vincent Morinière, Nathalie Boddaert, Marie Alice Macher, Brigitte Llanas, Hubert Nivet, Albert Bensman, Patrick Niaudet, Corinne Antignac, Remi Salomon, Sophie Saunier

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

Joubert syndrome (JS) is an autosomal recessive disorder that is described in patients with cerebellar ataxia, mental retardation, hypotonia, and neonatal respiratory dysregulation. Kidney involvement (nephronophthisis or cystic renal dysplasia) is associated with JS in one fourth of known cases. Mutations in three genes - AHI1, NPHP1, and NPHP6 - have been identified in patients with JS. However, because NPHP1 mutations usually cause isolated nephronophthisis, the factors that predispose to the development of neurologic involvement are poorly understood. In an attempt to identify such genetic determinants, a cohort of 28 families with nephronophthisis and at least one JS-related neurologic symptom were screened for mutations in AHI1, NPHP1, and NPHP6 genes. NPHP1 and NPHP6 homozygous or compound heterozygous mutations were found in 13 (46%) and six (21%) unrelated patients, respectively. Two of the 13 patients with NPHP1 mutations carried either a heterozygous truncating mutation in NPHP6 or a heterozygous missense mutation in AHI1. Furthermore, five patients with NPHP1 mutations carried the AHI1 variant R830W, which was predicted to be "possibly damaging" and was found with significantly higher frequency than in healthy control subjects and in patients with NPHP1 mutations without neurologic symptoms (five of 26 versus four of 276 and three of 152 alleles; P <0.001 and P <0.002, respectively). In contrast to the variable neurologic and milder retinal phenotype of patients with NPHP1 mutations, patients with NPHP6 mutations presented with a more severe neurologic and retinal phenotype. In conclusion, NPHP1 and NPHP6 are major genes of nephronophthisis associated with JS. Epistatic effects that are provided by heterozygous NPHP6 and AHI1 mutations and variants may contribute to the appearance of extrarenal symptoms in patients with NPHP1 mutations.

Original languageEnglish
Pages (from-to)1566-1575
Number of pages10
JournalJournal of the American Society of Nephrology
Volume18
Issue number5
DOIs
Publication statusPublished - May 2007

Fingerprint

Mutation Rate
Mutation
Nervous System
Neurologic Manifestations
Joubert syndrome 1
Genes
Phenotype
Kidney
Cerebellar Ataxia
Muscle Hypotonia
Missense Mutation
Intellectual Disability
Healthy Volunteers
Alleles

ASJC Scopus subject areas

  • Nephrology

Cite this

High NPHP1 and NPHP6 mutation rate in patients with Joubert syndrome and nephronophthisis : Potential epistatic effect of NPHP6 and AHI1 mutations in patients with NPHP1 mutations. / Tory, K.; Lacoste, Tiphanie; Burglen, Lydie; Morinière, Vincent; Boddaert, Nathalie; Macher, Marie Alice; Llanas, Brigitte; Nivet, Hubert; Bensman, Albert; Niaudet, Patrick; Antignac, Corinne; Salomon, Remi; Saunier, Sophie.

In: Journal of the American Society of Nephrology, Vol. 18, No. 5, 05.2007, p. 1566-1575.

Research output: Contribution to journalArticle

Tory, K, Lacoste, T, Burglen, L, Morinière, V, Boddaert, N, Macher, MA, Llanas, B, Nivet, H, Bensman, A, Niaudet, P, Antignac, C, Salomon, R & Saunier, S 2007, 'High NPHP1 and NPHP6 mutation rate in patients with Joubert syndrome and nephronophthisis: Potential epistatic effect of NPHP6 and AHI1 mutations in patients with NPHP1 mutations', Journal of the American Society of Nephrology, vol. 18, no. 5, pp. 1566-1575. https://doi.org/10.1681/ASN.2006101164
Tory, K. ; Lacoste, Tiphanie ; Burglen, Lydie ; Morinière, Vincent ; Boddaert, Nathalie ; Macher, Marie Alice ; Llanas, Brigitte ; Nivet, Hubert ; Bensman, Albert ; Niaudet, Patrick ; Antignac, Corinne ; Salomon, Remi ; Saunier, Sophie. / High NPHP1 and NPHP6 mutation rate in patients with Joubert syndrome and nephronophthisis : Potential epistatic effect of NPHP6 and AHI1 mutations in patients with NPHP1 mutations. In: Journal of the American Society of Nephrology. 2007 ; Vol. 18, No. 5. pp. 1566-1575.
@article{903a4ebfca4b485e8961f6395ea6211a,
title = "High NPHP1 and NPHP6 mutation rate in patients with Joubert syndrome and nephronophthisis: Potential epistatic effect of NPHP6 and AHI1 mutations in patients with NPHP1 mutations",
abstract = "Joubert syndrome (JS) is an autosomal recessive disorder that is described in patients with cerebellar ataxia, mental retardation, hypotonia, and neonatal respiratory dysregulation. Kidney involvement (nephronophthisis or cystic renal dysplasia) is associated with JS in one fourth of known cases. Mutations in three genes - AHI1, NPHP1, and NPHP6 - have been identified in patients with JS. However, because NPHP1 mutations usually cause isolated nephronophthisis, the factors that predispose to the development of neurologic involvement are poorly understood. In an attempt to identify such genetic determinants, a cohort of 28 families with nephronophthisis and at least one JS-related neurologic symptom were screened for mutations in AHI1, NPHP1, and NPHP6 genes. NPHP1 and NPHP6 homozygous or compound heterozygous mutations were found in 13 (46{\%}) and six (21{\%}) unrelated patients, respectively. Two of the 13 patients with NPHP1 mutations carried either a heterozygous truncating mutation in NPHP6 or a heterozygous missense mutation in AHI1. Furthermore, five patients with NPHP1 mutations carried the AHI1 variant R830W, which was predicted to be {"}possibly damaging{"} and was found with significantly higher frequency than in healthy control subjects and in patients with NPHP1 mutations without neurologic symptoms (five of 26 versus four of 276 and three of 152 alleles; P <0.001 and P <0.002, respectively). In contrast to the variable neurologic and milder retinal phenotype of patients with NPHP1 mutations, patients with NPHP6 mutations presented with a more severe neurologic and retinal phenotype. In conclusion, NPHP1 and NPHP6 are major genes of nephronophthisis associated with JS. Epistatic effects that are provided by heterozygous NPHP6 and AHI1 mutations and variants may contribute to the appearance of extrarenal symptoms in patients with NPHP1 mutations.",
author = "K. Tory and Tiphanie Lacoste and Lydie Burglen and Vincent Morini{\`e}re and Nathalie Boddaert and Macher, {Marie Alice} and Brigitte Llanas and Hubert Nivet and Albert Bensman and Patrick Niaudet and Corinne Antignac and Remi Salomon and Sophie Saunier",
year = "2007",
month = "5",
doi = "10.1681/ASN.2006101164",
language = "English",
volume = "18",
pages = "1566--1575",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "5",

}

TY - JOUR

T1 - High NPHP1 and NPHP6 mutation rate in patients with Joubert syndrome and nephronophthisis

T2 - Potential epistatic effect of NPHP6 and AHI1 mutations in patients with NPHP1 mutations

AU - Tory, K.

AU - Lacoste, Tiphanie

AU - Burglen, Lydie

AU - Morinière, Vincent

AU - Boddaert, Nathalie

AU - Macher, Marie Alice

AU - Llanas, Brigitte

AU - Nivet, Hubert

AU - Bensman, Albert

AU - Niaudet, Patrick

AU - Antignac, Corinne

AU - Salomon, Remi

AU - Saunier, Sophie

PY - 2007/5

Y1 - 2007/5

N2 - Joubert syndrome (JS) is an autosomal recessive disorder that is described in patients with cerebellar ataxia, mental retardation, hypotonia, and neonatal respiratory dysregulation. Kidney involvement (nephronophthisis or cystic renal dysplasia) is associated with JS in one fourth of known cases. Mutations in three genes - AHI1, NPHP1, and NPHP6 - have been identified in patients with JS. However, because NPHP1 mutations usually cause isolated nephronophthisis, the factors that predispose to the development of neurologic involvement are poorly understood. In an attempt to identify such genetic determinants, a cohort of 28 families with nephronophthisis and at least one JS-related neurologic symptom were screened for mutations in AHI1, NPHP1, and NPHP6 genes. NPHP1 and NPHP6 homozygous or compound heterozygous mutations were found in 13 (46%) and six (21%) unrelated patients, respectively. Two of the 13 patients with NPHP1 mutations carried either a heterozygous truncating mutation in NPHP6 or a heterozygous missense mutation in AHI1. Furthermore, five patients with NPHP1 mutations carried the AHI1 variant R830W, which was predicted to be "possibly damaging" and was found with significantly higher frequency than in healthy control subjects and in patients with NPHP1 mutations without neurologic symptoms (five of 26 versus four of 276 and three of 152 alleles; P <0.001 and P <0.002, respectively). In contrast to the variable neurologic and milder retinal phenotype of patients with NPHP1 mutations, patients with NPHP6 mutations presented with a more severe neurologic and retinal phenotype. In conclusion, NPHP1 and NPHP6 are major genes of nephronophthisis associated with JS. Epistatic effects that are provided by heterozygous NPHP6 and AHI1 mutations and variants may contribute to the appearance of extrarenal symptoms in patients with NPHP1 mutations.

AB - Joubert syndrome (JS) is an autosomal recessive disorder that is described in patients with cerebellar ataxia, mental retardation, hypotonia, and neonatal respiratory dysregulation. Kidney involvement (nephronophthisis or cystic renal dysplasia) is associated with JS in one fourth of known cases. Mutations in three genes - AHI1, NPHP1, and NPHP6 - have been identified in patients with JS. However, because NPHP1 mutations usually cause isolated nephronophthisis, the factors that predispose to the development of neurologic involvement are poorly understood. In an attempt to identify such genetic determinants, a cohort of 28 families with nephronophthisis and at least one JS-related neurologic symptom were screened for mutations in AHI1, NPHP1, and NPHP6 genes. NPHP1 and NPHP6 homozygous or compound heterozygous mutations were found in 13 (46%) and six (21%) unrelated patients, respectively. Two of the 13 patients with NPHP1 mutations carried either a heterozygous truncating mutation in NPHP6 or a heterozygous missense mutation in AHI1. Furthermore, five patients with NPHP1 mutations carried the AHI1 variant R830W, which was predicted to be "possibly damaging" and was found with significantly higher frequency than in healthy control subjects and in patients with NPHP1 mutations without neurologic symptoms (five of 26 versus four of 276 and three of 152 alleles; P <0.001 and P <0.002, respectively). In contrast to the variable neurologic and milder retinal phenotype of patients with NPHP1 mutations, patients with NPHP6 mutations presented with a more severe neurologic and retinal phenotype. In conclusion, NPHP1 and NPHP6 are major genes of nephronophthisis associated with JS. Epistatic effects that are provided by heterozygous NPHP6 and AHI1 mutations and variants may contribute to the appearance of extrarenal symptoms in patients with NPHP1 mutations.

UR - http://www.scopus.com/inward/record.url?scp=34248181986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248181986&partnerID=8YFLogxK

U2 - 10.1681/ASN.2006101164

DO - 10.1681/ASN.2006101164

M3 - Article

C2 - 17409309

AN - SCOPUS:34248181986

VL - 18

SP - 1566

EP - 1575

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 5

ER -